# Lamotrigine Extended Release

NDC: 49884-604
Generic name: lamotrigine extended release
Labeler / Manufacturer: Par Health USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20130118
Marketing ended: 20260930
FDA application: ANDA201791

## Active ingredients

- LAMOTRIGINE: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"49884-604"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49884-604
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fb59c76a-9b6f-40ea-ac3a-58c3195c4377